Acumen Pharmaceuticals annual free cash flow
2021
2022
2023
2024
2025
Acumen Pharmaceuticals Free Cash Flow (FCF) History (ABOS)
Acumen Pharmaceuticals reported −$115.6M in free cash flow for fiscal 2025, a decrease of $29.4M from the previous fiscal year.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$115.6M | −$29.4M | — | — |
| 2024 | 2024-12-31 | −$86.2M | −$43.1M | — | — |
| 2023 | 2023-12-31 | −$43.1M | −$7.8M | — | — |
| 2022 | 2022-12-31 | −$35.3M | −$17.3M | — | — |
| 2021 | 2021-12-31 | −$18.0M | — | — | — |
Acumen Pharmaceuticals quarterly free cash flow
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$18.1M | $13.8M | — | — |
| Q1 2026 | 2026-03-31 | −$24.1M | $10.1M | — | — |
| Q4 2025 | 2025-12-31 | −$19.1M | $8.1M | — | — |
| Q3 2025 | 2025-09-30 | −$30.5M | −$5.9M | — | — |
| Q2 2025 | 2025-06-30 | −$31.8M | −$15.3M | — | — |
| Q1 2025 | 2025-03-31 | −$34.2M | −$16.3M | — | — |
| Q4 2024 | 2024-12-31 | −$27.2M | −$18.9M | — | — |
| Q3 2024 | 2024-09-30 | −$24.6M | −$11.7M | — | — |
| Q2 2024 | 2024-06-30 | −$16.6M | −$4.9M | — | — |
| Q1 2024 | 2024-03-31 | −$17.9M | −$7.7M | — | — |
| Q4 2023 | 2023-12-31 | −$8.3M | $2.9M | — | — |
| Q3 2023 | 2023-09-30 | −$12.9M | −$3.6M | — | — |
| Q2 2023 | 2023-06-30 | −$11.7M | −$5.2M | — | — |
| Q1 2023 | 2023-03-31 | −$10.2M | −$1.9M | — | — |
| Q4 2022 | 2022-12-31 | −$11.2M | −$3.5M | — | — |
| Q3 2022 | 2022-09-30 | −$9.3M | — | — | — |
| Q2 2022 | 2022-06-30 | −$6.5M | — | — | — |
| Q1 2022 | 2022-03-31 | −$8.3M | — | — | — |
| Q3 2021 | 2021-09-30 | −$7.7M | — | — | — |
Acumen Pharmaceuticals free cash flow growth trends
Acumen Pharmaceuticals's latest reported quarter, Q2 2026, generated −$18.1M in free cash flow, an increase of $13.8M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Acumen Pharmaceuticals filings at SEC.gov ↗